Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
Clinical trial NCT04286607 · COMPLETED
Trial details
- NCT number
- NCT04286607
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2024-01-22
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.